0000899243-17-019943.txt : 20170809
0000899243-17-019943.hdr.sgml : 20170809
20170809171625
ACCESSION NUMBER: 0000899243-17-019943
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170807
FILED AS OF DATE: 20170809
DATE AS OF CHANGE: 20170809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lambing Joseph
CENTRAL INDEX KEY: 0001655816
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 171018879
MAIL ADDRESS:
STREET 1: C/O MYOKARDIA, INC.
STREET 2: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia Inc
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-07
0
0001552451
MyoKardia Inc
MYOK
0001655816
Lambing Joseph
C/O MYOKARDIA, INC.
333 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
See Remarks
Common Stock
2017-08-07
4
S
0
5000
25.00
D
119718
D
Common Stock
2017-08-07
4
S
0
5000
30.00
D
114718
D
Common Stock
2017-08-08
4
S
0
5000
35.00
D
109718
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Senior Vice President, Non-Clinical and Pharmaceutical Development
/s/ Jake Bauer, as Attorney-in-Fact
2017-08-09